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ABSTRACT 
 
Shewale,  Swapnil Vijay, M.S.,  Pharmacology/Toxicology Masters Program, 
Department  of Pharmacology and Toxicology, Wright State University,  
2011. Low Dose Nerve Agent Sarin Causes Dilated Cardio myopathy and 
Autonomic Imbalance 
            
           Sarin, a lethal chemical nerve agent, may be a causative fa ctor in 
multifactorial syndrome implicated in the Gulf War and Tokyo terrorist 
attacks.  While high dose results in seizure and death,  low dose exposure 
may lead to autonomic imbalance and chronic cardiac pathologies . In the 
present study, echocardiography and electrocardiography were used to 
examine the late onset effects of a low dose sarin on cardiac structure and 
function in mice. Stress responsiveness of the hypothalamic pituitary 
adrenal (HPA) axis was also tested . Findings demonstrate changes 
consistent with a dilated cardiomyopathy, including left  ventricular 
dilatation, reduced contractility,  and altered electrophysiological and 
inotropic responses  to β adrenergic stimulation.  Results also indicate 
altered stress responsiveness of HPA indicating autonomic imbalance . The 
role of low-dose sarin/organophosphate exposure needs to  be considered 
in military and civilian population who suffer from autonomic imbalance 
and/or cardiomyopathies of indeterminate origin.  
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I. Introduction 
 
I.1. Sarin: Structure, Function and Mechanism of Action  
           Sarin is  an irreversible acetyl  cholinesterase (AChE) inhibitor. It  
reacts with the Serine hydroxyl ( -OH) residue in the active site of  
Acetylcholinesterase (AChE) enzyme to form a phosphate or phosphonate 
ester rendering acetylcholinesterase inactive. Due to sarin induced 
inhibit ion of AChE, un-hydrolyzed acetylcholine (ACh) at  nerve synapses 
and neuromuscular junctions causes cholinergi c overstimulation leading to 
variety of symptoms including seizure and death . (McLeod, Jr., 1985; Marrs, 
1993) 
 
            Sarin is also knows as GB by military designation and belongs to 
group of organophospha te agents (OP’s) which have main applications as 
pesticides and nerve agents. Sarin is implicated as one of the etiological 
factors in Gulf war il lness. (Sharabi et al . ,  1991; McCauley et al. ,  2001)  
Also OP’s are widely used pesticides and cause approximately 200000 
deaths per year due to occupational (Farming) or accidental exposure and 
intentional use (in suicide attempts). (Dash, Mohanty, Mohanty, & Patnaik, 
2008; Dharmani & Jaga, 2005; London, Flisher,  Wesseling, Mergler, & 
Kromhout, 2005)  
                                        
Figure 1: General Chemical Structure of Nerve Agents (Augerson 2001) 
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Table 1: (Augerson 2001) Chemical Structure of Nerve Agents 
 
Agent  
 
X  R1  R2  
Tabun (GA)  CN  N(CH3)2  C2H5  
Sarin (GB)  F  CH3  CH(CH3)2  
Soman (GD)  F  CH3  CH(CH3)C(CH)3  
Cyclosarin (GF)  F  CH3  Cyclohexyl  
VX  SCH2CH2N- 
[CH(CH3)2]2  
CH3  
 
C2H5 
 
I.2. Mechanism of Action of OP’s 
            Organophosphates  cause cholinergic neurotoxicity by disrupting 
the cholinergic system that includes Acetyl cholinesterase (AChE) and its 
natural substrate,  acetylcholine (ACh). Acetylcholine is  released in 
response to nerve st imulation and binds to post -synaptic acetylcholine 
receptors, resulting in muscle contraction or gland secretions.  Its action is 
rapidly terminated by hydrolysis with AChE via the serine hydroxyl group 
in the catalytic triad of AChE.  
The 3-dimensional structure of AChE reveals an active center that  
includes the following sites (Fig. 2):   
(a) the catalytic triad: Glu 334, His 447, and Ser 203;  
(b) an aceyl pocket: Phe 295 and Phe 297;  
(c) a choline subunit: Trp 86, Glu 202, and Tyr 337; and  
(d) a peripheral si te:  Trp 286, Tyr 72, Tyr 124, and Asp 74.  
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Figure 2: Structure and active center of AChE (Adou-Donia 1992; Abou-Donia 2003) 
 
             Inhibition of AChE results in the accumulation of acetylcholine 
at both the muscarinic and nicotinic receptors in the central  nervous 
system (CNS) and the peripheral nervous system (PNS). Excess 
Acetylcholine initial ly causes excitation, and then paralysis,  of 
cholinergic transmission, resulting in some or all  of the cholinergic 
symptoms, depending on the dose size,  frequency of exposure,  duration of 
exposure, and route of exposure,  as well  as other factors such as combined 
exposure to other chemicals and individual s ensitivity and susceptibility.  
(Abou-Donia,  2003)  
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II. Background 
 
           During the 1980-1988 Iraq-Iran war both Iraq and Iran employed 
chemical weapons in an attempt to gain an advantage in a seemingly 
unending war (Ali 2001). The Japanese have experienced two separate 
terrorist attacks involving sarin. The first  occurred, in 1994, and nearly 
600 Japanese citizens were exposed to sarin in a neighborhood in 
Matsumoto, Japan. In 1995, the Aum Shinrikyo terrorist group deployed 
the sarin. During the 1990 US-Iraq Gulf War three sites were destroyed 
that  stored or contained munitions loaded with sarin and cyclo sarin.  Of 
the three sites,  the Khamisiyah site demolition is thought to have caused 
US troop exposure.  According to estimates,  nearly 90,000 troops may 
have been exposed to sarin and cyclosarin as a result  of the demolitions 
(Committee on Gulf War and Health: Updated Liter ature Review of Sarin 
2004), (Persian Gulf War Illnesses Task Force, 1997). As a result , sarin and other 
organophosphate nerve agents were implicated as a possible etiological 
agent in Gulf War Il lness and subsequently investigated by the US 
Department of Veterans Affairs (Couzin, 2004).  
 
  
Figure 3 A:  
   
  
  
Figure 3 B  
 
 
   
  
  
Figure 3: Demolition of bunkers at Khamisiyah, 4 March 1991 and Plume 
Models for the Demolition of Bunkers at Khamisiyah, 12 March 1991 
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III. Health effects of Sarin and current treatment 
 III.1. Symptoms seen in Gulf war veterans’ 
 
           Epidemiological studies enlist  the Gulf war veterans’  health 
outcomes in terms of mortality and hospitalization rates .  Population-based 
studies have  shown that  Gulf veterans have an unexpectedly high level of 
morbidity (Couzin, 2004; Steele, 2001; Chao, Rothlind, Cardenas, 
Meyerhoff, & Weiner, 2010; Haley, 2000; Riddle et  al .,  2003) .Kansas 
veterans study collected data on prevalence of chronic symptoms 
including respiratory, gastrointestinal,  neuropsychological,  sleep 
disturbances,  pain and neurologic/cognitive/mood symptoms  among 3138 
Gulf war and non Gulf war veterans.  The results indicate that, 7 years 
after serving in the Persian Gulf War, Kansas veterans experienced 
substantially more health problems than did era veterans who did not 
serve in the war. Increased morbidity was reflected in worse overall 
health status, higher rates of medical and psychiatric diagnoses, and more 
frequent and severe chronic symptoms  (Steele, 2000) . 
        The Gulf War veterans show variety of poorly defined neurological, 
muscular and autonomic symptoms including poorer cognitive function, 
tiredness, muscle and joint pain, loss of balance, bladder dysfunction, 
diarrhea etc.(Jamal,  Hansen, Apartopoulos, & Peden, 1996; Jamal,  1998) . 
Study conducted on Gulf war veterans and exposed to low levers of Sarin 
and Cyclosarin at Khamisiyah shows reduced visuospatial abil ities and 
psychomotor function in dose dependant manner (Proctor, Heaton, Heeren, 
& White, 2006).  Studies in Gulf war veterans also show altered diurnal 
patterns of Heart Rate (HR) and HR variability related to reduced 
parasympathetic drive possibly resulting from damage to CNS (Haley et  
al. ,  2004; Dabisch, To, Kerut, Horsmon, & Mioduszewski, 2007) .  
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      Previous study from this laboratory has shown delayed cardiac and 
central  autonomic effects of l ow dose sarin exposure in mice (Morris, 
Key, & Farah, 2007) .Recently,  some human data from the Aum Shinrikyo -
Tokyo subway attacks has indicated that  sarin could produce neurological 
and autonomic changes (Murata et al. ,  1997; Yokoyama et al. ,  1998) .  
Similarly,  Haley e t al have shown similar symptoms in veterans exhibiting 
GWI (Haley, 1997).  
III.2.Cardiovascualr Effects  
     
        Cardiovascular effects of OP on heart and blood vessels are complex 
effects of accumulated Acetylcholine. It has been shown that symptomatic 
dose of Sarin induces bradycardia, tachycardia, and arrhythmias in the  
heart that  can lead to spontaneous cardiac failure (Taylor, 2001; Marrs, 
2007).  Studies also show sufficient evidence for cardiotoxicity at delayed 
time points in rodent models and case studies of OP exposure survivors. 
Studies show evidences of long term QT prolongation, arrhythmias, 
various conduction problems, cardiomyopathy, and susceptibil ity to 
sudden death (Alaoui, Mossadeq, Faroudy, & Sbihi,  2009; Bar -Meir et al. ,  
2007; Gohel,  Oza, Panjwani,  & Gajjar,  1996; Marosi, Ivan, Vass, Gajdacs, 
& Ugocsai, 1989; Kiss & Fazekas, 1983) .   
 
Studies involving sarin in rats report  susceptibility to epinephrine 
induced arrhythmia and long QT syndrome upto 4 weeks (Allon, 
Rabinovitz, Manistersky, Weissman, & Grauer, 2005) .   Another study in 
rats shows QT prolongation and cardiac lesions for up to 12 weeks 
following a higher dose of sarin (Abraham, Oz, Sahar,  & Kadar, 2001) .   
As with the GWI data, the literature lacks sufficient background to 
pinpoint the risk to the cardiovascular system following a 
low/asymptomatic dose of nerve agent  sarin.   
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III.3. Current therapy for acute nerve agent / OP-poisoning  
 
1) An anticholinergic - like atropine (ATR) as a symptomatic tre atment  
it  is antagonist of the muscarinic ACh receptors and prevents excessive 
cholinergic stimulation. However, it  does not act on the nicotinic 
receptors.  
 
2) A cholinesterase (ChE) reactivator: Oxime’s such as pralidoxime 
(2PAM). Active AChE can be regenerated by the removal of the 
phosphoryl group by oxime drugs. However, this is not possible when the 
phosphorylated AChE undergoes aging.  
 
3) In addition to the above the therapy may also include an anti -seizure 
medication such as diazepam to prevent brain damage following seizure.   
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IV. Problem Statement, Hypothesis and Specific Aims 
 
IV.1. Problem Statement 
The current literature lacks sufficient information on low -
asymptomatic dose and late-onset effects of sarin on structure and 
function of the heart.  Treatment cannot be developed without 
characterizing such effects.  The literature lacks sufficient information 
about whether th is is  local , tissue (heart) specific  effect of Sarin or 
mediated via autonomic nervous system.  
 
IV.2. Hypothesis: 
 
         Low dose of organophosphates including nerve agents cause 
delayed, long term changes in  
1) Cardiovascular structure and function and  
2) Autonomic nervous system.  
 
IV.3 Specific Aims 
 
Aim 1- To test  the hypothesis that  low doses of Sarin causes cardiac 
remodeling and reduces cardiac function .  
 
Aim 2 –  To test  the hypothesis that low doses of Sarin causes autonomic 
imbalance analyzed using stress responsiveness  of hypothalamic pituitary 
adrenal (HPA) axis  and adrenal tyrosine hydroxylase  (TH) levels.  
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V. Methods 
V.1. Animal Protocol 
         Male C57BL/6J mice were purchased from Harlan Laboratories 
(Indianapolis,  IN). Body weight (BW) was ~25 gm. Mice were allowed a 1 
wk period to acclimate to the facility.  They were subjected to at least 3 
days of handling before experimental use. Mice were housed individually 
at 22°C with a 12:12-hour dark-light cycle and ad libitum  access to 
standard mouse chow and tap water.  All  procedures were approved by the 
Laboratory Animal Care and Use Committee of Wright State University,  
Dayton, OH.  
 
Groups  
Experiment 1: Time course of cardiovascular effects of sarin:  Mice 
were randomly divided into two groups: Sarin (0.4 LD 5 0) and Control 
(saline) with n = 12/group.   
Experiment 2: Time course of cardiovascular effects of dobu tamine in 
sarin treated mice:  Mice were randomly divided into two groups: Sarin 
(0.4 LD5 0) and Control (saline) with n = 12/ group.  Hearts from these 11 
wk experimental  mice were fixed, sectioned and stained for H&E and 
BNP.  
V.2. Sarin Exposure  
          
         Sarin (obtained from USAMRICD, Aberdeen Proving Ground, MD) 
was diluted in 0.9% saline and injected at a dose of 64μg/kg (0.4 LD 5 0). 
Sarin was injected subcutaneously in a volume of 0.5 ml/100gm BW on 
two consecutive days. The rationale for using two injec tions is  to promote 
the inhibition of AChE activity.  The first  injection scavenges 
carboxylesterase (CaE) found in high concentrations in rodents as 
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compared to humans. The second injection allows sarin access to AChE, 
promoting enzyme inhibition. The 0.4 LD5 0  dose was chosen because it is 
widely used and accepted as highest  asymptomatic dose which does not 
produce symptoms of cholinergic toxicity. Controls were injected with 
saline, same volume and regime.  
V.3. Cholinesterase Assay 
           
          Blood was col lected 24 hrs following the second sarin injection. 
Blood was collected by cheek puncture from the facial  vein in heparinized 
tubes and stored on ice until assay (within one hr).  Cholinesterase activity 
was measured by a modified version of the assay devel oped by Ellman et  
al.   (ELLMAN, COURTNEY, Andres, ,  & FEATHER -STONE, 1961) using 
a BIOTEKTM EL808 Micro plate Analyzer. Fresh whole blood was 
diluted (1:100) with 0.1 M NaPO4 pH 7.4. Total  ChE activity was 
measured in whole blood at  25ºC by inhibiting (BuChE) using 
tetraisopropylpyrophosphoramide (iso -OMPA). Butyryl ChE was 
determined as total  ChE minus AChE.  
V.4. Transthoracic Echocardiography 
         
        Echocardiograms (ECHO) were recorded using a Siemens®  
ACUSON Sequoia C512 ultrasound system with an ACUSON 15 
megahertz linear array transducer (model 15L8).  
 
        To determine left  ventricular (LV) structure and function, the 
parasternal long axis was used to obtain images via the parasternal apical 
window in 2 D B-Mode and 2 D M-Mode. Using 2 D B-Mode 
echocardiography, LV End Systolic and End diastolic areas were obtained 
where as M Mode was used to calculate LV End Systolic and End 
Diastolic Diameters. Stroke volume and cardiac output were obtained 
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using the inbuilt software of the echocardiography machine itself by 
feeding the calculated End Systolic and end Dias tolic areas during 
analysis in offline mode. The ESD, EDD  EDA, and ESA were then also 
used to obtain Fractional Shortening and other derived parameters. 
Transmitral  Doppler flow was traced in parasternal long axis view.   
 
ECHO procedure:  Mice were anesthet ized with 2% isoflurane in pure 
oxygen (500 ml/min) in an anesthesia chamber. Anesthesia was 
maintained using 1.5 % isoflurane delivered by nose cone.  Anesthetized 
mice were weighed, transferred to a heating pad and placed in a supine 
position.  Chest  hai r was removed using a commercial gel .  The transducer 
was coated with pre-warmed ul trasound transmission gel (Aqua sonic™ 
100, Parker Laboratories, Inc). Transthoracic t wo-dimensional guided M-
mode (2D M-mode) and two-dimensional (2D B-mode) images were 
obtained via the parasternal apical windows.   
Dobutamine Stress Test:  Following ECHO and EKG recording at baseline 
(2D B Mode, 2 D M Mode, Doppler, EKG), mice were injected with 
dobutamine (1 mg/kg, ip). The effect of the dobutamine was visually and 
acoustically obvious in the Doppler tracings after 1 -2 min.  
Offline ECHO analysis:  Analysis was performed by a single observer 
using the Siemens ACUSON Sequoia machine’s off -line analysis module.   
Another observer, inter -observer,  also analyzed a random sampling of the 
controls and sarin groups at  varying times to verify data quali ty.  Inter -
observer results did not vary significantly from the primary observer (< 
15 % intraobserver variability).  Three values were recorded and averaged 
for each parameter from each animal.  
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V.5. Electrocardiography (EKG) Methods 
 
Use of External Telemetry Probes :  A two-lead telemetry probe, (Data 
Sciences International (DSI) radio telemetry probe model # TA11ETA -F10 
(manufactured 15 May 2009) ),  was clipped to the shaved ches t area. The 
electrodes were clipped using a Schwartz micro-serrefine clip, and the 
transmitting end of the probe was placed over a DSI PhysioTel® receiver.    
EKG Acquisit ion :  Baseline EKG Tracings were recorded for 
approximately 3 minutes before injection of dobutamine (1 mg/kg IP). 
EKG tracings were recorded for an additional 7 minutes after dobutamine. 
This was done to ensure that  EKG recordings were captured after the 
dobutamine was effective.    
 
EKG Analysis:  EKG tracings were analyzed using DSI’s Ponemah™ 
software (version 4.90).   The software was set to record all available 
derived parameters under the channel input tab.   30 sec of the EKG 
tracings from before the dobutamine injection and 30 sec after the 
dobutamine injection were analyzed for each mouse.  
V.6. Body Weights 
       Body weights were collected 24 hours, four weeks, seven weeks, and 
10 weeks following the sarin injections.  
V.7. Urine Collection 
       Spot Urine samples were collected (~ 30 –  100 ul) using pipette by 
gently massaging the abdomen and stored on dry ice during collection and 
later in -80 freezer until analyzed. All urine samples were coll ected 
between 1600 to 2000 Hrs.  Urine  was collected at Baseline (Before 
Injection),  3 week, 6 week and at 9
t h
 week following sarin injection.  
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V.8. Cage Change Induced Stress Experiment 
 
         Mice were subjected to cage change induced stress and urine was 
collected at Baseline (before cage change), 30 min and 45 min from cage 
change. The object ive was to measure corticosterone (fight or flight 
glucocorticoids released from adrenal gland under stress) release in 
response to stress .  
V.9. ANP and BNP Staining and Quantification 
 
Tissue collection and processing : Mice were decapitated 12 wks after 
sarin injection. Hearts were  perfused with cold PBS, weighed  and fixed in 
4% paraformaldehyde (PFA) followed by 4% PFA/20% sucrose at 4°C. 
After 2 days of fixation, the tissues were stored  at −80°C until  sectioning.  
Hearts were sectioned (5 µm) using cryostat  and 3 sections were placed on 
each slide.   
 
BNP Immunohistochemistry:  
Slides were de-paraffinized by rinsing in increasing concentrations of 
ethanol (60 -100%). The sections were then washed in a (0.1 M) 
phosphate buffered saline (PBS) solution, subjected to 0.15% hydrogen 
peroxide (catalogue number 216763, Sigma Aldrich) for 15 minutes,  and 
rewashed. Sections were then blocked (with a normal goat serum (NSG) 
blocking solution) (catalogue number G9023, Sigma Aldrich) for one 
hour. After blocking, the sections were rewashed and st ained with the 
primary antibody 1/500 for BNP. The primary antibody was rabbit/anti -
rat; obtained from Bachem AG (Torrance, CA). The sections were allowed 
to incubate overnight prior to addition of secondary antibody.  The 
secondary antibody was goat/anti -rabbit (1:400). After a one hour 
incubation the sections were stained with an Elite® Vectastain™ ABC 
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stain kit  (rabbit Immoglobulin (IgG), catalogue number EK6101, 
VECTOR LABORATORIES, INC.,  Burlingame, CA) in conjunction with 
3-3’-Diaminobenzidine tetrahydrochloride (DAB) tablets ( catalogue 
number D3939, Sigma Aldrich) . Finally,  the slides were dehydrated,  
cleaned (with ethanol and xylene, respectively) and coversliped using 
paramount.  
 
A single observer used Molecular Devices®’ software package 
Metamorph® (version 7.6) to perform the analysis of the images.    
 
V.10. H&E Staining 
 
         Paraffin was removed from the slides containing 5 micron thick 
sections of the fixed heart tissue. The sections were washed, then 
submerged in a Gill II hematoxylin solution fo r 30 seconds, and rinsed 
with water for 5 to 10 minutes.  Ensuing hematoxylin, the sections were 
dehydrated (with xylene) and cover slipped with permount .  
 
V.11. Cell Size Quantification 
 
       Pictures were taken at 20X magnification of the heart  section s using 
the Leica Microsystems® DMR microscope .The light intensity,  
microscope settings,  and camera settings were setup as previously 
described and a single observer collected same day images using the same 
lighting and settings.    
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V.12. In situ hybridization (ISH) for TH mRNA 
 
        ISH was used to measure adrenal  TH mRNA as previously 
described(Key, Wirick, Cool, & Morris,  2001) .  The TH oligonucleotide 
probe (5′-CTGCTTGGTATCCTGCTC TGAGACGGCTCTTCTG-3′) 
targeted the 5′ untranslated region of mouse TH. Probes were 3′end -
labeled using terminal deox ynucleotidyl transferase (Roche Molecular 
Biochemicals, Indianapolis,  IN) with [35S] dATP (Life Science Products, 
Boston, MA). Slide mounted adrenal  sections (5 μm) were incubated with 
probe (∼0.5×106 cpm/100 μl). Hybridization bu ffer consisted of 50% 
deionized formamide, 4× SSC, 0.5 mM DTT, 10% dextran sulfate, 
1×Denhardt solution, 250 μg/ml sperm DNA and 250 μ g/ml yeast tRNA. 
Sections were mounted on slides and processed using a phosphor imaging 
system. For cel lular localization, slides were dipped in Kodak NTB2 
liquid emulsion (Sigma-Aldrich, St .Louis, MO) and developed after 2–4 
weeks.  
 
Figure 4 : Adrenal In-situ Hybridization(ISH): Representative Image 
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V.13. Spot Urine Collection and Cage Change Stress Experiment:  
 
          Spot Urine samples were collected by gentl y massaging the 
abdomen. Time of urine collection varied from 1600 -2000 hrs as highest 
concentration of corticosterone (correlated to circadian rhythm) was found 
in this time. Samples were collected at  baseline, 3rd and 6
t h
 week. In 7
t h
 
week cage change st ress was induced to determine stress responsiveness 
at 20 and 45 minutes from the cage change. Spot urine samples were 
collected before cage change and 20 and 45 minutes from cage change. 
Usual volume of urine collected varied from 70 -200 ul.0.5 M HCL was 
added in 1 /  10 proportion to urine and stored at  -80 degree Celsius unti l  
used.  
 
V.14. Corticosterone assay: Radioimmunoassay (RIA): 
 
           Corticosterone was determined with slight modifications in 
Corticosterone DA I 125 Radio Immuno Assay kit (MP Biomedical, LLC 
Diagnostic division Orangeburg, NY, USA). Diluted urine (1:  20 with dd 
H20) samples /  calibrators were mixed with Steroid diluent to which 
(radioactive labeled) Corticosterone I 121 was added followed by 
antiserum (anti corticosterone) and  incubated for 2 hrs.  Precipitating 
reagent was added and Samples were centrifuged at  2500 RPM for 15 min 
to separate bound I 121 corticosterone from unbound. Radioactivity was 
measured by gamma counter (Micromedic 4/200 plus).  Corticosterone 
levels for samples were obtained from the standard curve of the known 
concentrations of Cort . and expressed in ng/ml.   
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          Adrenal Corticosterone:  Adrenal glands were homogenized in 0.2 
N perchloric acid using Precellys 24 lysis and homogenization instrument 
from Bertin technologies.  Samples were homogenized at  3500 rpm x 30 
seconds. Adrenal homogenate was diluted 1:200 in steroid diluent  and 
analyzed using RIA.  
 
V.15. Protein Assay: 
            
          Adrenal homogenate (5ul was diluted to 795 ul dd H2O) and 
urinary protein content  was determined using colorimetric Bio -rad protein 
assay where protein concentration is obtained from standard curve 
obtained by using known concentration of BS A. 
V.16. Creatinine assay: EIA 
 
          Urinary corticosterone was cor rected by creatinine concentration in 
given sample of urine. An Enzyme Immuno assay (EIA) kit  (Quidel 
Corporation (Microvue Creatinine Assay Kit) San Diego, USA ) was used 
and quantity of creatinine was detected calorimetrically at 490 nm. Assay 
is based on modified Jaffe method where creatinine forms color solution 
with alkaline picrate.  
 
V.17. Statistical Analysis 
           
             Statistical  analysis of the mice was performed using 
STATISTICA software version 7.  In general , Two -way Repeated Measures 
Analysis of Variance (ANOVA) with Bonferoni post-hoc test was used to 
compare the Controls to the 0.4 LD 5 0  at different t ime points or at 
baseline and under drug treatment.  Finally,  when only two groups were 
analyzed a Student’s t -test  was used.    
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VI. Equations and Derived Parameters 
 
VI.1. ECHO Derived Parameters:  Fractional shortening (FS), relative wall 
thickness (RWT), area fraction shortening (aFS), and myocardial  
performance index (MPI) were calculated using following 
equations: (Morgan et al .,  2004; Syed, Diwan, & Hahn, 2005)   
 
Equation 1: Fractional Shortening Derived from M -mode Echocardiogram 
Images 
                                                             (1) 
 
Equation 2:  Relative Wall Thickness Derived from M -mode 
Echocardiogram Images  
 
                                                        (2) 
 
Equation 3: Area Fractional Shortening Derived from 2-D Echocardiogram 
Images 
                                                            (3) 
 
Equation 4: MPI Derived from Pulse Wave Doppler  
                                                                       (4) 
 
Derived parameters from the 2 -D geometric and Doppler temporal data 
aFS/MPI and the mean circumferential  fiber shortening velocity ( Vcf) 
were calculated.  Vcf was calculated using modified formulas presented 
by Broberg et  al .  (Broberg et al.,  2003)  
 
Equation 5:  Vcf derived from 2-D mode and Pulse Wave Doppler 
Echocardiograms 
 
           )/RR interval                                                (5)  
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Equation 6:  Cardiac Output                                                               
 
                         (6 )  
 
 
 
 
Figure 5: Representative Area 
Measurement Method for 2D 
Echocardiograms 
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Figure 6:Representative Measurement 
Methods for 2D M-mode Echocardiograms 
 
 
Figure 7: Example Pulsed Wave Doppler 
Image Showing Eight Full Sinus Rhythms 
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Figure 8:  Pulsed Wave Doppler Method 
of Quantification 
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VI.2. Electrocardiography Derived Parameters  
 
T-peak: Was defined as the lowest point on the T -wave after the end of 
the S-wave.  
T-end: Was placed where the T-wave crossed the apparent iso -electric 
line  
 
The “derived  data” from the Ponemah™ program was saved as a 
Microsoft® Excel™ file.  In addition, corrected QT (QT C) interval was 
calculated using a modified Brazett’s method with the Ponemah™ derived 
RR and QT intervals.   Mitchell  et  al showed that the high resting h eart 
rate of the mouse requires normalization of the RR interval to 100 
beats/min.(Mitchell , Jeron, & Koren, 1998)   
 
Equation 7:  Bazett/Mitchell QT Correction:  
 
                                                                       (7) 
 
 
Equation 8:   Corrected ST Segment Length  
 
    
                                                                             (8)                          
 
 
Equation 9:   Corrected Length of T peak to End of T  
 
                                                                                 (9) 
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Figure 9: Representative EKG:   
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Figure 9: Representative EKG Trace with Software Markings  
 
 
Figure 10: Calculation of T peak-T end:   
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Figure 10: EKG Trace Demonstrating S-T peak and Tpeak-Tend 
Calculations using QATN interval marked using software  
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VII. Figures and Results 
Note: All values are expressed as Mean ± Standard Error 
 
 Figure 11: Blood Cholinesterase Activity  
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Figure 11: Blood ChE activity was determined 24 hrs following the second 
sarin injection .  Total acetyl  and butyl ChE activity were significantly 
inhibited in sarin treated mice (approx 55 % drop in blood ChE activity). 
(* p < 0.05; ** p <0.01; students t test)  
 
Table 1: Body Weights  
 Body wt. Percent wt. gain (vs. baseline) 
 Control 0.4 LD50   Control 0.4 LD50 
Baseline Body Wt. (g) 30.8 ± 0.6 29.6± 0.4            0.0 %          0.0 % 
24 Hr after Sarin (g) 30.8 ± 0.6 28.9 ± 0.4* -0.027 ± 0.3 % -2.50 ± 0.54 % 
4 WK Body Wt. (g) 34.0 ± 0.9 30.8 ± 0.4*     10.2 ± 1.5 %     6.8 ± 1.4  % 
7 Wk Body Wt. (g) 36.2 ± 0.9 31.8 ± 0.9*      6.4  ± 0.7 %     3.1 ± 2.8  % 
10 WK Body Wt. (g) 39.3 ± 1.2 35.2 ± 0.8*       8.6 ± 0.8 %  10.7  ± 4.0  % 
 
Table 1: Sarin mice lost body weight after sarin injection and remained 
lower throughout the experiment .  All values are expressed as the Mean ± 
SE. Analyzed using student t  test.*   p < 0.05 when compared to controls, 
** p < 0.01 when compared to controls.  
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Figure 12: Cardiac Hemodynamics and Time Course of Left Ventricular 
Dilation in Sarin Mice  
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Figure 12: Sarin causes progressive cardiac  remodeling characterized by 
time dependent increases in LV area without changes in hemodynamic 
function .  EDA was increased in sarin treated mice at wk 4 (* p < 0.05) 
and wk 8 (** p < 0.01) vs. baseline (Fig 1A). ESA in sarin treated mice 
was higher compared to baseline at  wk 8 (** p=0.01) (Fig 1A). There was 
a trend towards reduced contractili ty, measured as % reduction in area 
fractional shortening, in sarin treated mice at wk 8 (Fig 1B).  LV dilation 
was not accompanied by changes in MAP, HR or relative L V wall 
thickness (Fig 1C, 1D, 1E). Data were analyzed using 2 -way ANOVA and 
post hoc test . (n=10/group) .  
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       Blood Cholinesterase and Body Weight:   All animals completed the 
experimental protocol until  euthanasia;  the injection paradigm produced 
no seizures, deaths or other behavioral symptoms. Following 24 hours of 
the second 0.4 LD50 sarin injection, blood acetyl , butyl  and total  
cholinesterase was inhibited by approximately 55% (Figure 11). Sarin led 
to approximately 1.5-2.0 gm body weight loss fol lowing second injection; 
however the weight gain after the injection d id not differ among the 
groups (Table 1).   
VII.1. Time course of sarin induced LV dilation 
         ECHO was performed before (baseline) and at 4 and 8 wks after 
sarin for measurements of cardiac structure and function. The low dose 
sarin produced time dependent progressive LV dilation. Specifically,  LV 
end diastolic area (EDA) and end systolic area (ESA) were significantly 
increased in sarin mice. There were no significant differences i n heart rate 
(HR) or mean arterial pressure (MAP) between control  and sarin mice, as 
measured using radiotelemetry.  There were no significant changes in 
posterior, septal , or relative wall thickness (RWT) measured using M 
Mode ECHO. However, a trend toward  reduced LV contractili ty,  measured 
using area fractional shortening (aFS),  was seen at 8 wks in sarin exposed 
mice (p=0.07). LV dilatation and reduced contractility occurred without 
alterations in MAP or LV wall thickness, consistent with remodeling seen 
in dilated cardiomyopathies (Figure 12).    
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Figure 13: Impaired cardiac function at baseline and under Dobutamine 
stress test  
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Figure 13: Sarin causes impaired systolic function at baseline and reduced 
myocardial performance and maximal cardiac contractility under β 
adrenergic st imulation.  Sarin treated mice (wk 11post exposure) showed 
increased EDA and ESA vs. controls (2A) that led to impaired baseline 
systolic function as determined by area fractional shortening (2B) and 
velocity of  circumferential fiber shortening (2C). Sarin treated mice 
under dobutamine stress showed reduced cardiac function measured as 
increased MPI (2D) and reduced maximal contractility as measured by 
FS/MPI (2E) and increased ICT+IVRT(2F). Data were analyzed using 2-
way ANOVA and post hoc test  (n=12/group) .  
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Table 2: Effect  Dobutamine stress test on ECHO parameters.  
ECHO  
PARAMETER 
 
Baseline Dobutamine 2Way Repeated ANOVA 
Control Sarin Control Sarin 
Effect of  
Group(Sarin) 
Control vs. Sarin 
Effect of 
Dobutamine 
Baseline 
vs.Dobutamine 
EDA  
(cm2) 0.195 ± 0.006 0.227 ± 0.007 0.177 ± 0.005 0.194 ± 0.007 
F(1, 18)=10.951, 
p=.00390 
F(1, 18)=18.375, 
 p=.00044 
ESA  
(cm2) 0.138 ± 0.007 0.173 ± 0.006 0.112 ± 0.005 0.127 ± 0.006 
F(1, 18)=17.464, 
p=.00056 
F(1, 18)=25.628, 
p=.00008 
Area FS 
 0.297 ± 0.016 0.238 ± 0.010 0.365 ± 0.020 0.341 ± 0.022 
F(1, 18)=5.9977, 
p=.02479 
F(1, 18)=20.120, 
p=.00029 
HR 
(bpm) 435 ± 14 394 ± 12 525 ± 16 491 ± 13 
F(1, 18)=5.3478, 
p=.03279 
F(1, 18)=60.229, 
p=.00000 
PWT  
(cm) 0.097 ± 0.004 0.098 ± 0.003 0.108 ± 0.003 0.110 ± 0.003 
F(1, 18)=.27577, 
p=.60590 
F(1, 18)=22.819, 
p=.00015 
SWT  
(cm) 0.103 ± 0.003 0.098 ± 0.005 0.110 ± 0.002 0.105 ± 0.003 
F(1, 16)=1.3252, 
p=.26657 
F(1, 16)=5.9388, 
p=.02686 
EDD  
(cm) 0.419 ± 0.008 0.427 ± 0.006 0.381 ± 0.008 0.366 ± 0.011 
F(1, 18)=.21839, 
p=.64588 
F(1, 18)=30.229, 
p=.00003 
ESD  
(cm) 0.259 ± 0.014 0.286 ± 0.007 0.184 ± 0.007 0.190 ± 0.011 
F(1, 18)=6.3777, 
p=.02116 
F(1, 18)=54.376, 
p=.00000 
FS 
 0.386 ± 0.024 0.331 ± 0.012 0.365 ± 0.020 0.341 ± 0.022 
F(1, 18)=8.4140, 
p=.00953 
F(1, 18)=38.502, 
p=.00001 
RWT 
 0.530 ± 0.022 0.453 ± 0.037 0.645 ± 0.024 0.668 ± 0.025 
F(1, 18)=.95587, 
p=.34119 
F(1, 18)=38.309, 
p=.00001 
ET  
(ms) 45.4 ± 1.3 50.3 ± 2.1 38.1 ± 1.2 40.4 ± 1.9 
F(1, 17)=2.7781, 
p=.11388 
F(1, 17)=32.209, 
p=.00003 
ICT+IVRT  
(ms) 26.2 ± 1.2 28.7 ± 1.3 18.7 ± 1.6 24.9 ± 2.0 
F(1, 17)=6.2974, 
p=.02251 
F(1, 17)=41.081, 
p=.00001 
Ao VMax 
 112.9 ± 12.0 128.8 ± 09.9 146.3 ± 08.9 157.7 ± 12.8 
F(1, 17)=2.0616, 
p=.16920 
F(1, 17)=8.0944, 
p=.01119 
Ao VTI 
(cm) 4.2 ± 0.11 4.6 ± 0.27 4.4 ± 0.23 5.4 ± 0.67 
F(1, 16)=1.8116, 
p=.19708 
F(1, 16)=1.6874, 
p=.21235 
C.O  
(ml/min) 14.34 ±2.34 14.87 ± 2.00 19.89 ± 0.76 22.84 ± 3.94 
F(1, 18)=.79035, 
p=.38572 
F(1, 18)=5.8117, 
p=.02683 
C.I       
(ml/min/kg) 398.6 ± 50.2 427.9 ± 70.6 519.0 ± 21.5 645.4 ± 98.2 
F(1, 17)=2.4159, 
p=.13853 
F(1, 17)=4.8578, 
p=.04159 
 
Table 2: Statistics of all ECHO parameters measured during dobutamine 
stress test .  All values are expressed as the Mean ± SE analyzed using 2 
way ANOVA and Bonferoni post  hoc test.  
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VII.2. Dobutamine stress test: Impaired stress response in sarin mice 
          
         At wk 11 post  sarin,  there was significant LV dilation as seen by 
the increase in EDA and ESA and impaired LV systolic f unction 
determined via aFS (Figure 13A, 13B). The velocity of circumferential  
fiber shortening (Vcfc) was also reduced  in sarin treated mice (Figure 
13C). With dobutamine stimulation, aFS and Vcfc were comparable in 
both groups, indicating that  given dose of dobutamine had produced a 
maximal contracti le effect.  
 
Myocardial  performance index (MPI) was obtained from Doppler for 
mitral flow and calculated using Tei’s index (Tei et al. ,  1995) . MPI was 
significantly increased under β adrenergic st imulation  in sarin treated 
mice (Figure 13D). Maximal cardiac contracti lity (+dP/dt max) 
characterized indirectly using FS/MPI (Broberg et al.,  2003)  was lower in 
sarin mice, indicating an impaired cardiac stress response (Figure 13E).  
Additionally,  isovolumetric contraction and relaxation time (ICT + IVRT) 
obtained from Doppler ECHO was significantly lengthened during 
dobutamine testing in the sarin mice.  
There were no significant alterations in posterior, septal or relative wall 
thickness. Hemodynamic measures of pump function including stroke 
volume and cardiac output did not differ significantly among groups 
(Table 2), indicating maintenance of corporal perfusion despite LV 
dilat ion and systolic dysfunction.  
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Figure 14: EKG  
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Figure 14: Severe ST depression and prolonged ventricular repolarization 
in sarin treated mice.  EKG tracings from the groups show severe ST 
depression in sarin mice after dobutamine st imulation. Tracings also 
show division of  ST segment of EKG tracing into S to T peak (STc) and T 
peak –  T end (Tc) intervals.  All data analyzed using 2 -way ANOVA and 
post hoc test . (n=12/group).  
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Figure 15: Effect  of Dobutamine stress test on EK G parameters  
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Heart Rate 
(bpm) 395± 11 394± 13 553 ± 36 521± 12
QRS 
(ms) 16.5 ± 0.8 18.2 ± 1.0 17.3 ± 0.9 19.5 ± 1.1
PR Interval 
(ms) 42.9 ± 1.4 42.0 ± 1.1 39.0 ± 2.7 44.2 ± 2.3
P Width 
(ms) 12.6 ± 0.7 14.2 ± 1.2 11.8 ± 0.6 14.6 ± 0.9
QT Interval 
(ms) 54.6 ± 7.0 57.5 ± 1.3 59.4 ± 7.2 64.3 ± 2.4
QTcorrected
44.2 ± 1.8 46.5 ± 1.0 56.5 ± 1.6 59.8 ± 1.8
T peak-T end 
(Tc) (ms) 17.3 ± 1.1 24.0 ± 1.7 25.9 ± 1.5 35.0 ± 1.8
S-T peak
(STc)(ms) 7.8 ± 2.0 11.7 ± 0.8 6.7 ± 1.9 13.2 ± 1.4
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Figure 15: Sarin mice had prolonged Tc interval at baseline as well as 
after dobutamine, indicating delayed ventricular repolarization .  No 
significant changes were seen in other EKG intervals.  All  data analyzed 
using 2-way ANOVA and post  hoc test. (n=12/group) .  
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VII.3. Electrocardiography:  
 
ST depression and pro-arrhythmic phenotype in sarin mice  
          Dobutamine resulted in prominent ST depression in sarin mice . In 
order to further characterize these ST segm ent changes,   T-peak to T-end 
interval was assessed as an indicator of global distribut ion of 
repolarization (Figures 14). Sarin mice had prolonged T-peak-T-end 
intervals at baseline and with dobutamine stimulation (Figure 15), 
indicating an increased dispersion of repolarization/ prolonged ventricular 
recovery in sarin mice which may result  in a predisposition to ventricular 
arrhythmias.  
 
Figure 16 :Histology  
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Figure 16: Cardiac Histology and Immunohistochemistry: Evidence o f 
cardiac remodeling and damage.  Sarin mice showed significantly 
increased heart to body weight ratio (6A)  LV cardiomyocytes were larger 
in sarin treated mice as seen in the H& E stained sections an d the image 
analysis data (Fig 6B).  LV BNP levels were higher in sarin mice (Fig 6C) 
suggestive of cardiac stretch.   
  
 
VII.4. Histological and Immunohistochemical evidence of cardiac remodeling 
        The heart weight ratios to body and kidney weight were significantly 
higher in sarin mice, (p< 0.05) (Figure 16A). LV cardiomyocyte cross 
sectional area was increased in sarin mice (p < 0.05) corroborating with 
LV remodeling (Figure 16B). Immunohistochemical staining revealed a 
significant increase in BNP (Brain Natriuretic Peptide) in LV of  mice 
exposed to sarin (Figure 16C); consistent with the observation that  sarin 
leads to cardiomyocyte and LV remodeling  
 
VII.5. Evidence for autonomic imbalance: Stress induced Hypothalamic–
pituitary–adrenal (HPA)-axis dysregulation 
           The adrenal TH mRNA levels determin ed using in-situ 
hybridization were significantly reduced in sarin group ( Figure 17A). 
Adrenal corticosterone content determined using radioimmunoassay on 
adrenal homogenate was significantly reduced as well  ( Figure 17B). Mice 
sacrificed under anesthesia induced stress had markedly different adrenal 
corticosterone content. Anesthesia induced marked elevation in 
cort/protein levels in controls however sarin mice failed to match up to 
controls.  Sarin mice had trend towards reduced urinary corticosterone 
compared to controls  (Figure 17C). Cage change induced stress led to 
significantly lower levels of urinary corticosterone over 45 minutes 
suggesting altered stress responsiveness and ceil ing effect to release of 
urinary Corticosterone under stress in sarin mice  (Figure 17D).  
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Figure 17: Autonomic Dysfunction seen as reduced adrenal TH mRNA, 
corticosterone and hyper -responsiveness of HPA axis to stress.  
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Figure 17: Sarin Induced Autonomic Dysfunction .  Sarin mice showed 
significantly reduced adrenal TH mRNA levels (A)  and adrenal 
corticosterone content (B). Sarin mice had trend towards reduced uri nary 
corticosterone levels (C) and exhibited  ceiling effect to release of urinary 
corticosterone on stress (D).  
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VIII. Discussion 
 
VIII.1. Sarin induced dilated cardiomyopathy  
          This is  the first report to show that low dose sarin results in 
delayed LV dilation and systoli c dysfunction. The findings are  notable 
given that  physiologic alterations in MAP and HR were absent. This 
phenotype is consistent with humans and animal models of a dilated 
cardiomyopathy and heart failure (Rajan et al. ,  2007; Fedak et  al .,  2004; 
Ikeda & Ross, Jr. ,  2000) . Cardiomyopathies are deleterious,  chronic 
conditions affecting a wide clinical spectrum for which effective 
treatments are limited (one year mortality rates of 30%) (Levy et  al .,  
2002; Ell iott  et  al.,  2008) . Sarin did not appear to change peripheral 
vascular resistance, indicating that the LV dilation was not secondary to 
hypertension.  Plausible explanations for the LV dilation include 
autonomic stimuli or direct cellular effects secondary to sarin.    
 
          To assess the mediators of the functional/s tructural changes, we 
tested the abil ity of a β adrenergic agonist, dobutamine, to stimulate 
cardiac function and reserve under stress. Independent  indices of cardiac 
function such as Vcfc, MPI and ICT+IVRT were obtained using ECHO. 
LV dilatation and reduced aFS were reco nfirmed at the 11 wk in sarin 
mice.  
 
          Vcfc,  cardiac preload independent index of cardiac function was 
reduced at baseline in sarin mice, indicating increased end systolic wall  
stress (Colan, Borow, & Neumann, 1984) .  Reduced Vcfc has also been 
reported in humans with dilated cardiomyopathy (Paraskevaidis, Tsiapras,  
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Adamopoulos, & Kremastinos, 1999) .  MPI is a clinically used diagnostic 
marker of combined LV systolic and diastolic function and is independent 
of HR, MAP and valvular incompetence. Increased MPI values suggest 
decreased global ventricular function in sarin t  mice. FS/MPI is an index 
of maximal cardiac contractility,  which was reduced in sarin mice. This 
indicates sarin reduces contractile reserve. FS/MPI and Vcfc served as 
relatively accurate indicators of global LV function which take into 
account both geometric and temporal measures of LV function  (Broberg et  
al. ,  2003).   
 
           To broaden our understanding of sarin’s effect on heart  we 
examined ECG traces. The QTc segment of ECG is  often used as a 
biomarker of susceptibility to sudden arrhythmias a nd QTc prolongation 
has been reported upon acute OP poisoning in humans (Shadnia,  Okazi,  
Akhlaghi,  Sasanian, & Abdollahi, 2009) .  In addition, rats given a 
convulsive dose of sarin had transiently prolonged QT C  interval at  2 wks 
which returned to normal after 4 wks (Roth, Zell inger, Arad, & Atsmon, 
1993).  In our study using low dose sarin, there were no changes in QTc 
segment, at least  at 11 wk post treatment.  However careful analysis of the 
ST segment using the T-peak-T-end interval shows that sarin mice had 
prolonged T peak-Tend at baseline as well as upon dobutamine.  This 
indicated an increased dispersion of ventricular repolarization, and a 
predisposition to ventricular arrhythmias.   
 
             ECG changes were more apparent in the stress test.  Prominent ST 
segment depression in sarin mice may indicate myocardial/sub-
endocardial ischemia (Chu et al. ,  2001)  (Tomai, Crea, Chiariello, & 
Gioffre, 1999) . Importantly,  this effect was seen almost  3 months after 
asymptomatic sarin exposure,  suggesting that  low -dose sarin can result in 
chronic cardiac electrophysiological  changes (Figure 3). These ECG 
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changes cannot be considered to be specific since they may result from 
alterations in cell membrane potential or intracellular effects such as 
mitochondrial  damage.  
             The heart weight / body weight ratio and heart weight / kidney 
weight ratio are common indexes used for comparison in various models 
of cardiac hypertrophy and stroke. The heart  weight /body weight ratio 
and heart  weight /  kidney weight ratio both were significantly higher in 
sarin mice indicating cardiac remodeling. Significantly increases cardiac 
mass, cardiomyocyte area and BNP (Brain Natriuretic  Peptide) expression 
in the sarin mice further suggest  a sarin induced cardiomyopathy. BNP is 
a peptide hormone synthesized and secreted exclusively by the heart in 
response to activation of neurohumoral and/or mechanical st imuli such 
that  occur during heart failure (Yasuno et al. ,  2009) .  ANP is  synthesized 
in atrial  myocytes wall stretch and cardiac stress .(Goetze, Georg, 
Jorgensen, & Fahrenkrug, 2010)  
 
              This study demonstrates that  low dose sarin exposure re sults in 
cardiac remodeling characterized by left  ventricular dilation, reduced 
systolic function, and delayed ventricular repolarization. These effects are 
further characterized by reduced myocardial performance, reduced 
maximal contracti lity and prominen t  ST segment depression under β 
adrenergic stimulation. These findings are consistent with early 
maladaptive changes that lead to cardiomyopathy and set the stage for the 
development of end-stage heart failure.  
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VIII.2. Sarin induced autonomic dysfunction:  
 
Stress induced Hypothalamic–pituitary–adrenal (HPA)-axis dysregulation  
           Stress induces neuroendocrine adaptations that enable the 
organism to survive and restore homeostasis. However, prolonged stress is 
a major contributor to the development of cardiovascular and 
neuropsychiatric disorders (Chrousos, 2000) . Key components mediating 
the broad physiological range of responses to stress include activation of 
the hypothalamic-pituitary-adrenocortical  axis (HPA)  and 
catecholaminergic systems . Classically,  the pituitary adrenocorticotr opic 
hormone (ACTH) under direction of the corticotropin releasing hormone 
(CRH) from the hypothalamus results in synthesis and release of 
glucocorticoids (including Corticosterone) from the adrenal cortex and the 
subsequent feedback inhibit ion is a well c haracterized response to stress  
(Belda et al. ,  2008; Dallman, 1993) . Tyrosine Hydroxylase  is  rate limiting 
enzyme in catecholamine synthesis and varieties of stressors have been 
reported to alter TH transcription. The consequent increase in TH protein 
is responsible for maintaining the appropriate levels of catecho lamine 
neurotransmitters during chronic or repeated stress  (Serova, Sabban, 
Zangen, Overstreet , & Yadid, 1998; Tank, Xu, Chen, Radcliffe, & 
Sterling, 2008; Sabban, Hiremagalur, Nankova, & Kvetnansky, 1995) .  
Lower levels of adrenal catecholamine’s  in case of co exposure to sarin 
and stress have been previously shown in mice at 7 weeks from 
exposure(Mach et al. ,  2008).  
             The observation of low urinary and adrenal corticosterone  levels 
in sarin treated mice can be counterintuitive,  however  i n cases of chronic 
stress or chronic illness such as depression, inc reased cortisol levels 
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indicate that the hypothalamic -pituitary- adrenal (HPA) axis has grown 
resistant to the effects of cortisol. In contrast, l ow cortisol  levels are 
associated with enhanced cortisol suppression after dexamethasone 
administration also seen in gulf war veterans (Golier, Schmeidler, Legge, 
& Yehuda, 2007; de Kloet et al .,  2007)  suggests that the HPA axis is 
actually overly responsive to stimulation/stress . The hypothesis that the 
HPA axis may be hypersensitive in sarin mice  is  consistent with the more 
general phenomenology of increased reactivity to both explicit  and 
implicit trauma reminders and as well  as a more generalized hyper 
vigilance in trauma survivors with this disorder. (Pitman, Orr, Forgue, de 
Jong, & Claiborn, 1987; Ottenweller,  Natelson, Pitman, & Drastal , 1989) .   
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IX. Conclusion 
 
 
           In summary these findings raise important health concerns related 
to the development  of autonomic imbalance and cardiomyopathy of 
indeterminate origin in both military and civil ian populations following 
exposure to low, non-symptomatic doses of the chemical warfare agent, 
sarin,  or other occupational OP pesticides.  The study also provides  a 
novel model of delayed onset cardiomyopathy in mice.  These results are 
particularly important in the military theater in which essentially healthy 
individuals may be exposed to the OP/stress combination.  Diminished 
cardiac function and altered stress re sponsiveness could explain the 
feeling of tiredness in these patients .  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
51 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
XI. Bibliography 
 
 
Books and Other References 
 
 
CDC. (1999). Background Document on Gulf War-Related Research for the Health 
Impact of Chemical Exposures During the Gulf War: A Research Planning Conference. 
Atlanta GA: CDC (Center for Disease Control and Prevention) , pp. 55 
 
Central Intelligence Agency; Department of Defense. (1997, 09 4). Modeling the 
Chemical Warfare Agent Release at the Khamisiyah Pit. Retrieved 02 09, 2010, from 
CIA Home: https://www.cia.gov/library/reports/general-reports-
1/gulfwar/555/425055597.html 
 
Committee on Gulf War and Health: Updated Literature Review of Sarin. (2004). Gulf 
War and Health: Updated Literature Review of Sarin. In Gulf War and Health: Updated 
Literature Review of Sarin (pp. 14 - 17). Washington DC: National Academy of Sciences. 
 
Conover, M. B. (2003). Understanding Electrocardiography, p. 34-40. St. Louis: Mosby, 
Inc. 
 
52 
 
 
Eroschenko, V. P. (2008). diFiore's Atlas of Histology with Functional Correlations 
(11th ed.). Baltimore MD: Lippincott Williams & Wilkins. 
 
Marrs, T. C. (2007). Toxicology of Organophosphate Nerve Agents. In T. C. Marrs, R. L. 
Maynard, & F. R. Sidell, Chemcial Warfare Agents Toxicology and Treatment (pp. 191 - 
223). West Sussex, England: John Wiley & Sons Ltd. 
 
Mirvis, D. M., & Goldberger, A. L. (2008). CHAPTER 12 – Electrocardiography. In P. 
Libby, R. O. Bonow, D. L. Mann, & D. P. Zipes, BRAUNWALD'S Heart Disease A 
Textbook of Cardiovascular Medicine (pp. 149 - 195). Philadelphia PA: Saunders, an 
imprint of Elsevier Inc. 
 
Taylor, P. (2001). Anticholinesterase Agents. In J. G. Hardman, L. E. Limbird, & A. G. 
Gilman, Goodman & Gilman's: The Pharmacological Basis of Therapeutics (pp. 175-
191). New York NY: McGraw Hill Companies, Inc. 
 
Persian Gulf War Illnesses Task Force. (1997, 04 02). Khamisiyah: A Historical 
Perspective on Related Intelligence. Retrieved 02 09, 2010, from GulfLINK: 
http://www.gulflink.osd.mil/cia_wp/ 
 
Roden, D. M. (2001). Antiarrhythmic Drugs. In J. G. Hardman, L. Limbird, & A. G. 
Gilman, Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th ed.) 
(pp. 935 - 970). New Yoyk NY: McGraw - Hill. 
 
Taylor, P. (2001). Anticholinesterase Agents. In J. G. Hardman, L. E. Limbird, & A. G. 
Gilman, Goodman & Gilman's: The Pharmacological Basis of Therapeutics (pp. 175-
191). New York NY: McGraw Hill Companies, Inc. 
 
 
53 
 
United States Air Force. (2007, January 26). Counter-Chemical, Biological, Radiological, 
and Nuclear Operations. Air Force Doctrine Document 2-1.8 . Headquarters Air Force 
Doctrine Center. 
 
 
 
 
 
 
 
 
 
 
 
Article Reference List 
 
Abou-Donia, M. B. (2003). Organophosphorus ester-induced chronic 
neurotoxicity. Arch.Environ.Health, 58, 484-497. 
Abraham, S., Oz, N., Sahar, R., & Kadar, T. (2001). QTc prolongation and cardiac 
lesions following acute organophosphate poisoning in rats. Proc.West Pharmacol.Soc., 
44, 185-186. 
Alaoui, M. Y., Mossadeq, A., Faroudy, M., & Sbihi, A. (2009). [Cardiac 
complications associated with organophosphate poisoning.]. Ann.Cardiol.Angeiol.(Paris). 
Allon, N., Rabinovitz, I., Manistersky, E., Weissman, B. A., & Grauer, E. (2005). 
Acute and long-lasting cardiac changes following a single whole-body exposure to sarin 
vapor in rats. Toxicol.Sci., 87, 385-390. 
 
54 
 
Bar-Meir, E., Schein, O., Eisenkraft, A., Rubinshtein, R., Grubstein, A., Militianu, A. 
et al. (2007). Guidelines for treating cardiac manifestations of organophosphates 
poisoning with special emphasis on long QT and Torsades De Pointes. Crit Rev.Toxicol., 
37, 279-285. 
Belda, X., Rotllant, D., Fuentes, S., Delgado, R., Nadal, R., & Armario, A. (2008). 
Exposure to severe stressors causes long-lasting dysregulation of resting and stress-
induced activation of the hypothalamic-pituitary-adrenal axis. Ann.N.Y.Acad.Sci., 1148, 
165-173. 
Broberg, C. S., Pantely, G. A., Barber, B. J., Mack, G. K., Lee, K., Thigpen, T. et al. 
(2003). Validation of the myocardial performance index by echocardiography in mice: a 
noninvasive measure of left ventricular function. J.Am.Soc.Echocardiogr., 16, 814-823. 
Chao, L. L., Rothlind, J. C., Cardenas, V. A., Meyerhoff, D. J., & Weiner, M. W. 
(2010). Effects of low-level exposure to sarin and cyclosarin during the 1991 Gulf War on 
brain function and brain structure in US veterans. Neurotoxicology. 
Chrousos, G. P. (2000). The role of stress and the hypothalamic-pituitary-adrenal 
axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-
related causes. Int.J.Obes.Relat Metab Disord., 24 Suppl 2, S50-S55. 
 
55 
 
Chu, V., Otero, J. M., Lopez, O., Morgan, J. P., Amende, I., & Hampton, T. G. 
(2001). Method for non-invasively recording electrocardiograms in conscious mice. BMC 
Physiol, 1, 6. 
Colan, S. D., Borow, K. M., & Neumann, A. (1984). Left ventricular end-systolic 
wall stress-velocity of fiber shortening relation: a load-independent index of myocardial 
contractility. J.Am.Coll.Cardiol., 4, 715-724. 
Couzin, J. (2004). Epidemiology. VA advisers link Gulf War illnesses to 
neurotoxins. Science, 306, 26-27. 
Dabisch, P. A., To, F., Kerut, E. K., Horsmon, M. S., & Mioduszewski, R. J. (2007). 
Multiple exposures to sarin vapor result in parasympathetic dysfunction in the eye but 
not the heart. Toxicol.Sci., 99, 354-361. 
Dallman, M. F. (1993). Stress update Adaptation of the hypothalamic-pituitary-
adrenal axis to chronic stress. Trends Endocrinol.Metab, 4, 62-69. 
Dash, S. K., Mohanty, M. K., Mohanty, S., & Patnaik, K. K. (2008). 
Organophosphorus poisoning: victim specific analysis of mortality and morbidity. 
Med.Sci.Law, 48, 241-245. 
de Kloet, C. S., Vermetten, E., Heijnen, C. J., Geuze, E., Lentjes, E. G., & 
Westenberg, H. G. (2007). Enhanced cortisol suppression in response to dexamethasone 
 
56 
 
administration in traumatized veterans with and without posttraumatic stress disorder. 
Psychoneuroendocrinology, 32, 215-226. 
Dharmani, C. & Jaga, K. (2005). Epidemiology of acute organophosphate 
poisoning in hospital emergency room patients. Rev.Environ.Health, 20, 215-232. 
Elliott, P., Andersson, B., Arbustini, E., Bilinska, Z., Cecchi, F., Charron, P. et al. 
(2008). Classification of the cardiomyopathies: a position statement from the European 
Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur.Heart 
J, 29, 270-276. 
ELLMAN, G. L., COURTNEY, K. D., Andres, V., , Jr., & FEATHER-STONE, R. M. 
(1961). A new and rapid colimetric determination of acetylcholinesterase activity. 
Biochem Pharmacol, 7, 88-95. 
Fedak, P. W., Smookler, D. S., Kassiri, Z., Ohno, N., Leco, K. J., Verma, S. et al. 
(2004). TIMP-3 deficiency leads to dilated cardiomyopathy. Circulation, 110, 2401-2409. 
Gilat, E., Kadar, T., Levy, A., Rabinovitz, I., Cohen, G., Kapon, Y. et al. (2005). 
Anticonvulsant treatment of sarin-induced seizures with nasal midazolam: an 
electrographic, behavioral, and histological study in freely moving rats. 
Toxicol.Appl.Pharmacol., 209, 74-85. 
 
57 
 
Goetze, J. P., Georg, B., Jorgensen, H. L., & Fahrenkrug, J. (2010). Chamber-
dependent circadian expression of cardiac natriuretic peptides. Regul.Pept., 160, 140-
145. 
Gohel, D. R., Oza, J. J., Panjwani, S. J., & Gajjar, P. P. (1996). Organophosphate 
compound poisoning and cardiac toxicity. J.Assoc.Physicians India, 44, 287. 
Golier, J. A., Schmeidler, J., Legge, J., & Yehuda, R. (2007). Twenty-four hour 
plasma cortisol and adrenocorticotropic hormone in Gulf War veterans: relationships to 
posttraumatic stress disorder and health symptoms. Biol.Psychiatry, 62, 1175-1178. 
Haley, R. W. (1997). Is Gulf War syndrome due to stress? The evidence 
reexamined. Am.J.Epidemiol., 146, 695-703. 
Haley, R. W. (2000). Re: "Factor analysis of self-reported symptoms: does it 
identify a Gulf War syndrome?". Am.J.Epidemiol., 152, 1204-1206. 
Haley, R. W., Vongpatanasin, W., Wolfe, G. I., Bryan, W. W., Armitage, R., 
Hoffmann, R. F. et al. (2004). Blunted circadian variation in autonomic regulation of 
sinus node function in veterans with Gulf War syndrome. Am.J.Med., 117, 469-478. 
Ikeda, Y. & Ross, J., Jr. (2000). Models of dilated cardiomyopathy in the mouse 
and the hamster. Curr.Opin.Cardiol., 15, 197-201. 
Ip, M. S., Scott, I. U., VanVeldhuisen, P. C., Oden, N. L., Blodi, B. A., Fisher, M. et 
al. (2009). A randomized trial comparing the efficacy and safety of intravitreal 
 
58 
 
triamcinolone with observation to treat vision loss associated with macular edema 
secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for 
Retinal Vein Occlusion (SCORE) study report 5. Arch.Ophthalmol., 127, 1101-1114. 
Jamal, G. A. (1998). Gulf War syndrome--a model for the complexity of biological 
and environmental interaction with human health. Adverse Drug React.Toxicol.Rev., 17, 
1-17. 
Jamal, G. A., Hansen, S., Apartopoulos, F., & Peden, A. (1996). The "Gulf War 
syndrome". Is there evidence of dysfunction in the nervous system? 
J.Neurol.Neurosurg.Psychiatry, 60, 449-451. 
Key, M., Wirick, B., Cool, D., & Morris, M. (2001). Quantitative in situ 
hybridization for peptide mRNAs in mouse brain. Brain Res.Brain Res.Protoc., 8, 8-15. 
Kiss, Z. & Fazekas, T. (1983). Organophosphate poisoning and complete heart 
block. J.R.Soc.Med., 76, 85-86. 
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. et al. 
(2002). Long-term trends in the incidence of and survival with heart failure. 
N.Engl.J.Med, 347, 1397-1402. 
London, L., Flisher, A. J., Wesseling, C., Mergler, D., & Kromhout, H. (2005). 
Suicide and exposure to organophosphate insecticides: cause or effect? Am.J.Ind.Med., 
47, 308-321. 
 
59 
 
Mach, M., Grubbs, R. D., Price, W. A., Nagaoka, M., Dubovicky, M., & Lucot, J. B. 
(2008). Delayed behavioral and endocrine effects of sarin and stress exposure in mice. 
J.Appl.Toxicol., 28, 132-139. 
Marosi, G., Ivan, J., Vass, K., Gajdacs, A., & Ugocsai, G. (1989). [ECG 
repolarization disorder (QT lengthening) in organophosphate poisoning]. Orv.Hetil., 130, 
111-115. 
Marrs, T. C. (1991). Toxicology of oximes used in treatment of organophosphate 
poisoning. Adverse Drug React.Toxicol.Rev., 10, 61-73. 
Marrs, T. C. (1993). Organophosphate poisoning. Pharmacol.Ther., 58, 51-66. 
McCauley, L. A., Rischitelli, G., Lambert, W. E., Lasarev, M., Sticker, D. L., & 
Spencer, P. S. (2001). Symptoms of Gulf War veterans possibly exposed to 
organophosphate chemical warfare agents at Khamisiyah, Iraq. 
Int.J.Occup.Environ.Health, 7, 79-89. 
McLeod, C. G., Jr. (1985). Pathology of nerve agents: perspectives on medical 
management. Fundam.Appl.Toxicol., 5, S10-S16. 
Mitchell, G. F., Jeron, A., & Koren, G. (1998). Measurement of heart rate and Q-T 
interval in the conscious mouse. Am.J.Physiol, 274, H747-H751. 
Morgan, E. E., Faulx, M. D., McElfresh, T. A., Kung, T. A., Zawaneh, M. S., Stanley, 
W. C. et al. (2004). Validation of echocardiographic methods for assessing left 
 
60 
 
ventricular dysfunction in rats with myocardial infarction. Am.J.Physiol Heart 
Circ.Physiol, 287, H2049-H2053. 
Morris, M., Key, M. P., & Farah, V. (2007). Sarin produces delayed cardiac and 
central autonomic changes. Exp.Neurol., 203, 110-115. 
Murata, K., Araki, S., Yokoyama, K., Okumura, T., Ishimatsu, S., Takasu, N. et al. 
(1997). Asymptomatic sequelae to acute sarin poisoning in the central and autonomic 
nervous system 6 months after the Tokyo subway attack. J.Neurol., 244, 601-606. 
Ottenweller, J. E., Natelson, B. H., Pitman, D. L., & Drastal, S. D. (1989). 
Adrenocortical and behavioral responses to repeated stressors: toward an animal model 
of chronic stress and stress-related mental illness. Biol.Psychiatry, 26, 829-841. 
Paraskevaidis, I. A., Tsiapras, D. P., Adamopoulos, S., & Kremastinos, D. T. (1999). 
Assessment of the functional status of heart failure in non ischemic dilated 
cardiomyopathy: an echo-dobutamine study. Cardiovasc.Res., 43, 58-66. 
Pitman, R. K., Orr, S. P., Forgue, D. F., de Jong, J. B., & Claiborn, J. M. (1987). 
Psychophysiologic assessment of posttraumatic stress disorder imagery in Vietnam 
combat veterans. Arch.Gen.Psychiatry, 44, 970-975. 
Proctor, S. P., Heaton, K. J., Heeren, T., & White, R. F. (2006). Effects of sarin and 
cyclosarin exposure during the 1991 Gulf War on neurobehavioral functioning in US 
army veterans. Neurotoxicology, 27, 931-939. 
 
61 
 
Rajan, S., Ahmed, R. P., Jagatheesan, G., Petrashevskaya, N., Boivin, G. P., 
Urboniene, D. et al. (2007). Dilated cardiomyopathy mutant tropomyosin mice develop 
cardiac dysfunction with significantly decreased fractional shortening and myofilament 
calcium sensitivity. Circ.Res, 101, 205-214. 
Riddle, J. R., Brown, M., Smith, T., Ritchie, E. C., Brix, K. A., & Romano, J. (2003). 
Chemical warfare and the Gulf War: a review of the impact on Gulf veterans' health. 
Mil.Med., 168, 606-613. 
Roth, A., Zellinger, I., Arad, M., & Atsmon, J. (1993). Organophosphates and the 
heart. Chest, 103, 576-582. 
Sabban, E. L., Hiremagalur, B., Nankova, B., & Kvetnansky, R. (1995). Molecular 
biology of stress-elicited induction of catecholamine biosynthetic enzymes. 
Ann.N.Y.Acad.Sci., 771, 327-338. 
Serova, L., Sabban, E. L., Zangen, A., Overstreet, D. H., & Yadid, G. (1998). Altered 
gene expression for catecholamine biosynthetic enzymes and stress response in rat 
genetic model of depression. Brain Res.Mol.Brain Res., 63, 133-138. 
Shadnia, S., Okazi, A., Akhlaghi, N., Sasanian, G., & Abdollahi, M. (2009). 
Prognostic value of long QT interval in acute and severe organophosphate poisoning. 
J.Med Toxicol., 5, 196-199. 
 
62 
 
Sharabi, Y., Danon, Y. L., Berkenstadt, H., Almog, S., Mimouni-Bloch, A., Zisman, 
A. et al. (1991). Survey of symptoms following intake of pyridostigmine during the 
Persian Gulf war. Isr.J.Med.Sci., 27, 656-658. 
Steele, L. (2000). Prevalence and patterns of Gulf War illness in Kansas veterans: 
association of symptoms with characteristics of person, place, and time of military 
service. Am.J.Epidemiol., 152, 992-1002. 
Steele, L. (2001). Invited commentary: unexplained health problems after Gulf 
War Service--finding answers to complex questions. Am.J.Epidemiol., 154, 406-409. 
Syed, F., Diwan, A., & Hahn, H. S. (2005). Murine echocardiography: a practical 
approach for phenotyping genetically manipulated and surgically modeled mice. 
J.Am.Soc.Echocardiogr., 18, 982-990. 
Tank, A. W., Xu, L., Chen, X., Radcliffe, P., & Sterling, C. R. (2008). Post-
transcriptional regulation of tyrosine hydroxylase expression in adrenal medulla and 
brain. Ann.N.Y.Acad.Sci., 1148, 238-248. 
Tei, C., Ling, L. H., Hodge, D. O., Bailey, K. R., Oh, J. K., Rodeheffer, R. J. et al. 
(1995). New index of combined systolic and diastolic myocardial performance: a simple 
and reproducible measure of cardiac function--a study in normals and dilated 
cardiomyopathy. J.Cardiol., 26, 357-366. 
 
63 
 
Tomai, F., Crea, F., Chiariello, L., & Gioffre, P. A. (1999). Ischemic preconditioning 
in humans: models, mediators, and clinical relevance. Circulation, 100, 559-563. 
Yasuno, S., Usami, S., Kuwahara, K., Nakanishi, M., Arai, Y., Kinoshita, H. et al. 
(2009). Endogenous cardiac natriuretic peptides protect the heart in a mouse model of 
dilated cardiomyopathy and sudden death. Am.J Physiol Heart Circ.Physiol, 296, H1804-
H1810. 
Yokoyama, K., Araki, S., Murata, K., Nishikitani, M., Okumura, T., Ishimatsu, S. et 
al. (1998). Chronic neurobehavioral and central and autonomic nervous system effects 
of Tokyo subway sarin poisoning. J.Physiol Paris, 92, 317-323. 
 
 
 
 
